Multiple Sclerosis: IL-2 and sIL-2R levels in cerebrospinal fluid and serum. Review of literature and critical analysis of ELISA pitfalls

Multiple Sclerosis

Volumn 4, Issue 1, 1998, Pages 7-11

  Sivieri, S ^a   Ferrarini, A M ^a   Gallo, P ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

IL 2; Multiple sclerosis; sIL 2R

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR;

BODY FLUID; CEREBROSPINAL FLUID; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MULTIPLE SCLEROSIS; SERUM; SHORT SURVEY; STANDARDIZATION;

EID: 0031934163     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859800400103     Document Type: Short Survey

References (30)

1. Tavolato B, Gallo P. (1994) Intrathecal cytokine synthesis in inflammatory and demyelinating diseases of the central nervous system. In: S Salvati (Ed), A multi-disciplinary approach to myelin diseases II, Plenum Press, New York, pp 167-175.
2. Gallo P, Tavolato B. (1996) Cytokines in multiple sclerosis cerebrospinal fluid and serum. In: EJ Thompson, M Trojano, P Livrea (Eds), Cerebrospinal fluid analysis in multiple sclerosis, Springer-Verlag, Milano, pp 93-104.
3. Voskul RR, Martin R, Bergman C et al. (1993) T helper 1 (Th1) functional phenotype of human myelin basic protein specific T lymphocytes. Autoimmunity 15: 137-142.
4. Correale J, McMillan M, McCarthy K et al. (1995) Isolation and characterization of autoreactive proteolipid protein-peptide specific T-cell clones from multiple sclerosis. Neurology 45: 1370-1378.
5. Hofman FM, van Hanwehr RI, Dinarello CA et al. (1986) Immunoregulatory molecules and IL-2 receptors identified in multiple sclerosis brain. J Immunol 136: 3239-3245.
6. Peter JB, Boctor FN, Tourtellotte WW. (1991) Serum and CSF levels of IL-2, sIL-2R, TNFα and IL-1β in chronic progressive multiple sclerosis: expected lack of clinical utility. Neurology 41: 121-123.
7. Weller M, Stevens A, Sommer N et al. (1991) Comparative analysis of cytokine pattern in immunological, infectious, and oncological neurological diseases. J Neurol Sci 104: 215-221.
8. Gallo P, Piccinno MG, Pagni S, Tavolato B. (1988) Interleukin-2 levels in serum and cerebrospinal fluid of multiple sclerosis patients. Ann Neurol 24: 795-797.
9. Adachi K, Kumamoto T, Araki S. (1989) Interleukin-2 receptor levels indicating relapse in multiple sclerosis (Letter). Lancet i: 559-560.
10. Gallo P, Piccinno MG, Pagni S et al. (1989) Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and IFNγ in serum and cerebrospinal fluid. J Neurol Sci 92: 9-15.
11. Adachi K, Kumamoto T, Araki S. (1990) Elevated soluble interleukin-2 receptor levels in patients with active multiple sclerosis. Ann Neurol 28: 687-691.
12. Trotter JL, van der Veen RC, Clifford DB. (1990) Serial studies of interleukin-2 in chronic progressive multiple sclerosis: occurrence of 'bursts' and effect of cyclosporine. J Neuroimmunol 28: 9-14.
13. Gallo P, Piccinno MG, Tavolato B, Sidèn Å. (1991) A longitudinal study on IL-2, sIL-2R, IL-4 and IFNγ in mutliple sclerosis CSF and serum. J Neurol Sci 101: 227-232.
14. Hartung H-P, Reiners K, Schmidt B et al. (1991) Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis. Ann Neurol 30: 48-53.
15. Trotter JL, Collins KG, van der Veen RC. (1991) Serum cytokine levels in chronic progressive multiple sclerosis: interleukin-2 levels parallel tumor necrosis factor-α levels. J Neuroimmunol 33: 29-36.
16. Sharief MK, Hentges R, Thompson EJ. (1991) The relationship of interleukin-2 and soluble interleukin-2 receptors to intrathecal immunoglobulin synthesis in patients with multiple sclerosis. J Neuroimmunol 32: 43-51.
17. 2microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosis. J Neurol 241: 108-114.
18. Sharief MK, Thompson EJ. (1993) Correlation of interleukin-2 and soluble interleukin-2 receptors with clinical activity of multiple sclerosis. J Neurol Neurosur Psychiatry 56: 169-174.
19. Greenberg SJ, Marcon L, Hurwitz BJ et al. (1988) Elevated levels of soluble interleukin 2 receptors in multiple sclerosis (Letter). N Engl J Med 319: 1206.
20. Capra R, Mattioli F, Marciano N et al. (1990) Significantly higher levels of soluble interleukin 2 in patients with relapsing-remitting multiple sclerosis compared to healthy subjects (Letter). Arch Neurol 47: 254.
21. Hartung H-P, Hughes RAC, Taylor WA et al. (1990) T cell activation in Guillain-Barré syndrome and in MS: elevated serum levels of soluble IL-2 receptors. Neurology 40: 215-218.
22. Kittur SD, Kittur DS, Soncrant TT et al. (1990) Soluble interleukin-2 receptors in cerebrospinal fluid from individuals with various neurological disorders. Ann Neurol 28: 169-173.
23. Bansil S, Troiano R, Cook SD, Rohowsky-Kochan C. (1991) Serum soluble interleukin-2 receptor levels in chronic progressive, stable, and steroid treated multiple sclerosis. Acta Neurol Scand 84: 282-285.
24. Fesenmeier JT, Whitaker JN, Herman PK, Walker DP. (1991) Cerebrospinal fluid levels of myelin basic protein-like material and soluble interleukin-2 receptor in multiple sclerosis. J Neuroimmunol 34: 77-80.
25. Chalon MP, Sindic CJM, Laterre EC. (1993) Serum and CSF levels of soluble interleukin-2 receptors in MS and other neurological diseases: a reappraisal. Acta Neurol Scand 87: 77-82.
26. Sharief MK, Hentges R, Ciardi M, Thompson EJ. (1993) In vivo relationship of interleukin-2 and soluble interleukin-2 receptor with clinical activity in multiple sclerosis. J Neurol 240: 46-50.
27. Link J, Söderström M, Olsson T et al. (1995) Increased TGFβ, IL-4 and IFNγ in multiple sclerosis. Ann Neurol 36: 379-386.
28. Rieckmann P, Albrecht B, Kitze B et al. (1995) Tumor necrosis factor-α messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann Neurol 37: 82-88.
29. Jung T, Schauer U, Heusser C et al. (1993) Detection of intracellular cytokines by flow cytometry. J Immunol Meth 159: 197-207.
30. Openshaw P, Murphy EE, Hosken NA et al. (1995) Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and 2 population. J Exp Med 182: 1357-1367.